Patent · US Active

Anti-cancer polyketide compounds

US9604973B2 · kind B2 · utility

2Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 26, 2014
Grant dateMar 28, 2017
Priority date
Expiry dateSep 26, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D313/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, are anticancer polyketides. The uses of the polyketides described herein include treatment of cancer, for example, through regulation of the spliceosome and detection of spliceosome inhibition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.